Search research articles
Contact Us
Filters
Showing results (111-120 of 1,938) with videos related to
Page
of 194
Sort By:
Annals of Internal Medicine
|
February 12, 1998
Feasibility and utility of adding disease-specific outcome measures to administrative databases to improve disease management
M H Liang, N Shadick
Journal of Molecular Biology
|
January 31, 1998
Three-dimensional structures of proteins involved in programmed cell death
H Liang, S W Fesik
ACS Medicinal Chemistry Letters
|
August 20, 2025
Preparation of Novel PARP1 Inhibitors and Their Use in Cancer Treatment
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
January 14, 2026
Novel Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) Inhibitors for Cancer Treatment
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
January 14, 2026
Novel Substituted Aryl Sulfonamides and Sulfuric Diamides As Transglutaminase 2 Inhibitors
Jian Rong, Steven H Liang
ACS Medicinal Chemistry Letters
|
January 14, 2026
Novel 2,4,6-Trisubstituted 1,3,5-Triazines as CX3CR1 Modulators for the Treatment of Cardiovascular Disorders
Taoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters
|
July 16, 2025
Synthesis of Novel Substituted <i>N</i>‑Heterocycles and Their Use of Selective Poly(ADP-ribose) Polymerase 1 (PARP1) Inhibitors
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
July 16, 2025
Selective Modulation of the GluN2B/C/D Containing <i>N</i>‑Methyl‑d‑Aspartate Receptors: A New Frontier in Targeted Neurotherapeutics
Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters
|
October 15, 2025
Development of Novel Compounds and Methods for Treatment of PARPs Mediated Disease
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
May 14, 2025
PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational Medicine
Taoqian Zhao, Steven H Liang
Page
of 194
Search research articles
Search
Showing results (111-120 of 1,938) with videos related to
Sort By:
Page
of 194
Annals of Internal Medicine
|
February 12, 1998
Feasibility and utility of adding disease-specific outcome measures to administrative databases to improve disease management
M H Liang, N Shadick
Journal of Molecular Biology
|
January 31, 1998
Three-dimensional structures of proteins involved in programmed cell death
H Liang, S W Fesik
ACS Medicinal Chemistry Letters
|
August 20, 2025
Preparation of Novel PARP1 Inhibitors and Their Use in Cancer Treatment
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
January 14, 2026
Novel Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) Inhibitors for Cancer Treatment
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
January 14, 2026
Novel Substituted Aryl Sulfonamides and Sulfuric Diamides As Transglutaminase 2 Inhibitors
Jian Rong, Steven H Liang
ACS Medicinal Chemistry Letters
|
January 14, 2026
Novel 2,4,6-Trisubstituted 1,3,5-Triazines as CX3CR1 Modulators for the Treatment of Cardiovascular Disorders
Taoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters
|
July 16, 2025
Synthesis of Novel Substituted <i>N</i>‑Heterocycles and Their Use of Selective Poly(ADP-ribose) Polymerase 1 (PARP1) Inhibitors
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
July 16, 2025
Selective Modulation of the GluN2B/C/D Containing <i>N</i>‑Methyl‑d‑Aspartate Receptors: A New Frontier in Targeted Neurotherapeutics
Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters
|
October 15, 2025
Development of Novel Compounds and Methods for Treatment of PARPs Mediated Disease
Xin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters
|
May 14, 2025
PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational Medicine
Taoqian Zhao, Steven H Liang
Page
of 194